SHA:605116

2 stories mentioning SHA:605116Updated 5d ago

Every FINWIRES story that references SHA:605116, newest first.

Aurisco Pharmaceutical Subsidiary's Worksops Pass US FDA Inspection; Shares Rise 3%

Aurisco Pharmaceutical (SHA:605116) subsidiary Yangzhou Aurisco Pharmaceutical's quality management system passed an inspection by the U.S. Food and Drug Administration, according to a Thursday filing with the Shanghai bourse.The FDA inspected Yangzhou Aurisco's workshops in Jiangsu, China from June 15 to 19, covering its production facilities and found the workshops to be in compliance with current good manufacturing practice standards, the filing said.Shares rose 3% during afternoon trading on Thursday.

SHA:605116

Asia99d ago

Aurisco Pharmaceutical Obtains Registration Certificate for HIV Drug

Aurisco Pharmaceutical (SHA:605116) received a registration certificate from China's National Medical Products Administration for its dolutegravir sodium tablets, according to a Shanghai bourse filing on Tuesday.The drug is used for the treatment of human immunodeficiency virus (HIV) in combination with other antiretroviral drugs.The pharmaceutical company invested 14.2 million yuan in the drug's research and development.

SHA:605116

Track with the FINWIRES app suite

FolioX

Track SHA:605116 in your portfolio

WheelAI

Analyze SHA:605116 options with the wheel strategy

StockInsider

See market sentiment on SHA:605116